Carlisle Companies Incorporated (CSL)

Debt-to-capital ratio

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Long-term debt US$ in thousands 1,886,700 2,281,100 2,575,400 2,080,200 1,341,400
Total stockholders’ equity US$ in thousands 2,829,000 3,024,400 2,629,500 2,537,700 2,642,800
Debt-to-capital ratio 0.40 0.43 0.49 0.45 0.34

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $1,886,700K ÷ ($1,886,700K + $2,829,000K)
= 0.40

The debt-to-capital ratio for Carlisle Companies Inc. has fluctuated over the past five years. In 2023, the ratio was 0.45, slightly lower than the previous year but higher than the ratios in 2020 and 2019. The ratio indicates that Carlisle Companies Inc. uses debt to finance 45% of its capital structure, while the remaining 55% is financed through equity. This suggests that the company's reliance on debt has been moderate and relatively stable in recent years. It is important to monitor the trend of this ratio to assess the company's leverage position and financial risk.


Peer comparison

Dec 31, 2023

Company name
Symbol
Debt-to-capital ratio
Carlisle Companies Incorporated
CSL
0.40
West Pharmaceutical Services Inc
WST
0.02